BONEH — BBS-Bioactive Bone Substitutes Oyj Share News
0.000.00%
Brief: BBS Postpones AGM
Brief: BBS FY Net Result Swings To Loss EUR 1.6 Mln
Brief: BBS-Bioactive Bone Substitutes Says Clinical Result Of Artebone Is Positive Yielding An Outcome Similar To Patient's Own Bone Graft
Brief: BBS-Bioactive Bone Substitutes Patent Application Accepted In Canada
Brief: BBS-Bioactive Bone Substitutes Names Ilkka Kangasniemi New CEO
Brief: BBS-Bioactive Bone Substitutes H1 Net Loss Narrows To EUR 0.8 Million
Brief: BBS Gets Around SEK 3.2 Million From Share Issue
Brief: BBS Announces Subscription Price Of Its Ongoing Share Issue 28,10 SEK
Brief: BBS Completes Final Manufacturing Steps For CE Marking
Brief: BBS Announces Share Issue Of About SEK 12.7-16.8 Mln
Brief: BBS-Bioactive Bone Substitutes FY Net Profit At EUR 379,000
Brief: BBS H1 Operating Result Swings To Profit Of EUR 1.1 Mln